229910052799 carbon Inorganic materials 0.000 claims description 20.125000001072 heteroaryl group Chemical group 0.000 claims description 21.125000000217 alkyl group Chemical group 0.000 claims description 26.150000002431 hydrogen Chemical group 0.000 claims description 27.125000003118 aryl group Chemical group 0.000 claims description 28.150000002367 halogens Chemical class 0.000 claims description 34.229910052736 halogen Inorganic materials 0.000 claims description 34.125000002619 bicyclic group Chemical group 0.000 claims description 39.206010012818 Diffuse large B-cell lymphoma Diseases 0.000 claims description 39.125000001931 aliphatic group Chemical group 0.000 claims description 43.229910052739 hydrogen Inorganic materials 0.000 claims description 44.125000000623 heterocyclic group Chemical group 0.000 claims description 48.-1 or Ci- C Chemical group 0.000 claims description 77.QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 96.MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical group O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 108.229910052760 oxygen Inorganic materials 0.000 claims description 109.NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical group NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 110.125000005842 heteroatoms Chemical group 0.000 claims description 112.229910052757 nitrogen Inorganic materials 0.000 claims description 138.239000011780 sodium chloride Substances 0.000 claims description 143. ![]() IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 167.150000001875 compounds Chemical class 0.000 claims abstract description 315.Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority claimed from US201962949298P external-priority Application filed by Kymera Therapeutics, Inc. ![]() Priority date (The priority date is an assumption and is not a legal conclusion. Weiss Original Assignee Kymera Therapeutics, Inc. Google Patents WO2021127190A1 - Irak degraders and uses thereof ![]() WO2021127190A1 - Irak degraders and uses thereof
0 Comments
Leave a Reply. |